News

Vedat’s product portfolio includes plastic closures, PET bottles and other plastic containers and the majority of its customers are in the South American pharmaceutical industry. Gerresheimer CEO Uwe

The dementia drug is supplied by Janssen Pharmaceutical under an agreement signed between the companies. As per the terms of the agreement, Reminyl will be marketed by Takeda

Tesaro intends to discover compounds for oncology indication as well as for the treatment of the patients with non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. The

Curemark said it has reached its target of enrolling 170 patients in this autism drug trial. Curemark medical director Bill Gannon said they have been extremely pleased with

The study was designed to evaluate the overall survival in unresectable stage III or stage IV melanoma patients who have not received prior therapy. The study compared ipilimumab

ARI-3037MO is a structural analog of niacin to treat mixed lipid disorders and hypercholesterolemia in 93 million Americans. Successful completion of preclinical pharmacology and toxicology studies by Arisaph

The study results revealed that none of the AP doses showed statistically significant improvements over placebo in the analysis of the primary endpoint. Analyses of key secondary endpoints

The meeting was held particularity to address topics central to definition of the applicable patient population and primary endpoint for the Phase 3 randomized controlled trial (RCT) of

Zevalin is a CD20-directed radiotherapeutic antibody. Zevalin injection for intravenous use is indicated for the treatment of patients with previously untreated follicular non-Hodgkin’s Lymphoma (NHL), who achieve a